371 related articles for article (PubMed ID: 2101347)
21. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
[TBL] [Abstract][Full Text] [Related]
22. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
Sheehy MJ
Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
[TBL] [Abstract][Full Text] [Related]
23. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
[TBL] [Abstract][Full Text] [Related]
24. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a german population.
Badenhoop K; Donner H; Pani M; Rau H; Siegmund T; Braun J
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S89-92. PubMed ID: 10522814
[TBL] [Abstract][Full Text] [Related]
25. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
Ferber KM; Keller E; Albert ED; Ziegler AG
J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
[TBL] [Abstract][Full Text] [Related]
27. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families.
Noble JA; Valdes AM; Cook M; Klitz W; Thomson G; Erlich HA
Am J Hum Genet; 1996 Nov; 59(5):1134-48. PubMed ID: 8900244
[TBL] [Abstract][Full Text] [Related]
28. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes.
Deschamps I; Marcelli-Barge A; Lallemand N; Poirier JC; Bochu V; Prévost P; Busson A; Massét M; Lestradet H; Hors J
Tissue Antigens; 1988 May; 31(5):259-69. PubMed ID: 3400091
[TBL] [Abstract][Full Text] [Related]
29. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies.
Robles DT; Eisenbarth GS; Wang T; Erlich HA; Bugawan TL; Babu SR; Barriga K; Norris JM; Hoffman M; Klingensmith G; Yu L; Rewers M;
Clin Immunol; 2002 Mar; 102(3):217-24. PubMed ID: 11890708
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of HLA genetic factors in IDDM susceptibility.
Martell M; Marcadet A; Moine A; Boitard C; Deschamps I; Dausset J; Bach JF; Cohen D
Immunogenetics; 1990; 31(4):233-40. PubMed ID: 1970333
[TBL] [Abstract][Full Text] [Related]
31. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
32. HLA and IDDM: facts and speculations on the disease gene and its mode of inheritance.
Rubinstein P
Hum Immunol; 1991 Apr; 30(4):270-7. PubMed ID: 2045289
[TBL] [Abstract][Full Text] [Related]
33. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
[TBL] [Abstract][Full Text] [Related]
34. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
[TBL] [Abstract][Full Text] [Related]
35. HLA DQA1 and DQB1 study in Algerian type 1 diabetes families.
Beressi JP; Djoulah S; Khalil I; Benhamamouch S; Bessaoud K; Touhami M; Hors J; Deschamps I
Diabete Metab; 1992; 18(6):451-8. PubMed ID: 1297602
[TBL] [Abstract][Full Text] [Related]
36. Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility.
Khalil I; Deschamps I; Lepage V; al-Daccak R; Degos L; Hors J
Diabetes; 1992 Mar; 41(3):378-84. PubMed ID: 1551498
[TBL] [Abstract][Full Text] [Related]
37. DNA polymorphism analysis of HLA class II genes in unrelated children and in first-degree relatives with type I diabetes.
Jos J; Farkas D; de Tand MF; Cartron J; Cohen-Hagenhauer O; Tozzo E; Deschamps I
Diabetes Res; 1991 Oct; 18(2):53-9. PubMed ID: 1688161
[TBL] [Abstract][Full Text] [Related]
38. HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls.
Kockum I; Wassmuth R; Holmberg E; Michelsen B; Lernmark A
Am J Hum Genet; 1993 Jul; 53(1):150-67. PubMed ID: 8317480
[TBL] [Abstract][Full Text] [Related]
39. Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children.
Walldén J; Ilonen J; Roivainen M; Ludvigsson J; Vaarala O;
Scand J Immunol; 2008 Sep; 68(3):345-50. PubMed ID: 18782261
[TBL] [Abstract][Full Text] [Related]
40. [HLA association of insulin-dependent diabetes mellitus type I (author's transl)].
Bertrams J; Sodomann P; Gries FA; Sachsse B; Jahnke K
Dtsch Med Wochenschr; 1981 Jul; 106(29-30):927-32. PubMed ID: 7021118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]